SOX18 and the transcriptional regulation of blood vessel development

Trends Cardiovasc Med. 2001 Nov;11(8):318-24. doi: 10.1016/s1050-1738(01)00131-1.

Abstract

SOX18 is a transcription factor that is transiently expressed in nascent endothelial cells during embryonic development and adult neovascularization. This protein belongs to the SOX family of transcription factors, which are proving to be some of the key regulators of cell-type specification in the vertebrate embryo. Natural mutations in the Sox18 gene have been shown to result in cardiovascular dysfunction, in some cases leading to death. Available evidence thus implicates Sox18 as an important regulator of vascular development, most likely playing a key role in endothelial cell specification. However, the genetic knockout of Sox18 in mice has produced a confounding result that complicates our understanding of the molecular mode of action of the SOX18 protein. We speculate that Sox18 may act in a redundant fashion with closely related genes such as Sox7 and/or Sox17.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / genetics*
  • Gene Expression Regulation, Developmental
  • High Mobility Group Proteins / genetics
  • High Mobility Group Proteins / physiology*
  • Humans
  • Mice
  • Mice, Knockout
  • Mutation
  • Myogenic Regulatory Factors / chemistry
  • Myogenic Regulatory Factors / genetics
  • Myogenic Regulatory Factors / metabolism
  • Neovascularization, Physiologic / genetics*
  • SOXF Transcription Factors
  • Transcription Factors / genetics
  • Transcription Factors / physiology*

Substances

  • High Mobility Group Proteins
  • Myogenic Regulatory Factors
  • SOX18 protein, human
  • SOXF Transcription Factors
  • Sox18 protein, mouse
  • Transcription Factors